Skip to content

Apotheek Antverpia

Active Public limited companyfounded 1968active for 58 yearsBlauwesteenstraat 95, 2550 KontichKBO/BCE: BE 0404.751.702 #2 employer in Kontich, Wholesale and retail trade sector

Lifetime

17 annual accounts with figures on one time axis, 48 filings since 1977
peak of €65.9m in 2023
€65.6m▼ 0.5%
lowest -€511,564 in 2023
€449,079▲ €960,643
peak of €4.3m in 2024
€4.3m▲ 16.6%
€12.2m▼ 53.2%
peak of 172.5 FTE in 2024
172.5 FTE▲ 39.2%
Board10 names since 2012
4 directors and 3 others
Documentsfilings and deeds
29-08-202529 days late
2024financial year
Profit of €449,079, after a lossStaff from 123.9 FTE to 172.5 FTEMerger: Apotheek Antverpia takes over VITAFARMA 26-08Merger proposal: APOTHEEK ANTVERPIA takes over VITAFARMA 10-06Company renamed from Apoteek Antverpia to Apotheek Antverpia 01-02Equity from €3.7m to €4.3m

Key points

from the 2024 annual accounts

Result

€449,079 €449,079
-€512,0002023€449,0002024

Back in profit in 2024, after a loss of €511,564 in 2023.

Debts

€12.2m 74% of the balance sheet
Financial debts 15%Suppliers 65%Taxes and wages 12%Other 8%

Of this, €10.6m falls due within a year.

Staff

134 employees on 31-12-2024
1511202021455451202291690820234,5414,5292024

In 2024, 4,541 short contracts started and 4,529 ended, on average 53 hours worked per contract. Staff averaged 173 full-time equivalents.

Payment terms

50 days to suppliers
Suppliers
127 to 50
Customers
109 to 36

Apotheek Antverpia pays its suppliers 77 days earlier than in 2023. Customers pay 73 days earlier.

Filings

48 annual accounts 110 days past the deadline
AprilJune31 JulyOctober198019952010

2025 accounts not filed: deadline was 31-07-2026.

Restructuring

3
  • 26-08-2024 merger with VITAFARMA
  • 26-08-2024 merger with FARMA DE BOND
  • 26-08-2024 merger with B.V.B.A.

3 restructurings since 2024. Merger with B.V.B.A. , the latest on 26-08-2024.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 736 companies had the same profile as Apotheek Antverpia has now. Each dot stands for 2 companies, two years later.

97.3%
were still trading
1.5%
stopped another way
1.0%
went bankrupt
  • Medium-sized
  • 20 years or older
  • solvency 10 to 30%
  • a profit under 5% of the balance sheet

Another 0.3% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 736 companies, not a prediction for Apotheek Antverpia. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Managing director,
Managing director,
Managing director,
Managing director,
Auditor,

Shares in 1 company,

Board & ownership

Recent changes

° appointed as statutory auditor acts as permanent representative · General meeting of 01-10-2025 · Gazette deed
Environmental permit granted Functiewijziging, Verbouwen en/of uitbreiden met functiewijziging en met wijziging van aantal woongelegenheden · Kontich
Merger: Apotheek Antverpia takes over VITAFARMA General meeting of 03-07-2024 · Gazette deed
Merger proposal: APOTHEEK ANTVERPIA takes over VITAFARMA , , and act as permanent representatives · Gazette deed
All 70 events

Comparable companies

same main activity, similar in size and age
Company
Apotheek Antverpia Kontich €65.6m 1.1% 26.2% 172.5
COOP-APOTHEKEN Ghent €85.3m 1.1% 41.4% 227.1
LES PHARMACIES DU PEUPLE - Réseau Solidaris Seraing €44.8m 1.0% 36.4% 129.3
PHARMACIES SERVAIS Wavre €52.2m 5.2% 27.6% 139.7
M.D.D. PHARMA Wavre €28.6m 3.0% 4.6% 104.8
UNIVERSAL PHARMA Frameries €51.5m 4.4% 73.1% 134.5
BIOPHARM Kortenberg €10.3m 1.8% 44.7% -
-10%0%10%20%€10m€100m€1bnApotheek AntverpiaEBIT margin

Grey: the largest companies of the sector (retail trade (NACE 47)), without their names. Blue: the sector peers from the table.

These companies have the same main activity as Apotheek Antverpia: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €12m and €32m, founded between 1901 and 1994.

Official details

Source: KBO
Status
ActiveNormal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Joint committee
313Pharmacies and pricing offices · annual accounts 2024
Establishment units
2.004.205.9812000 Antwerp, since 01-01-1961
2.004.206.0802650 Edegem, since 01-01-1961and 9 others
Financial year end
31 December
Peppol
Reachable
Company details

Annual accounts 2024

€16.6m▼ 44.5%
Employeeson 31-12-2024
134▲ 1.5%
Filing
Filed on 29-08-2025
Financials

Insights on Apotheek Antverpia

Apotheek Antverpia has existed since 1968. Turnover grew from €18.4m in 2010 to €65.6m in 2024 and staff from 44.4 to 172.5 full-time equivalents.

Solvency rose in 2024 from 12.4% to 26.2% because of the retained profit and a capital increase and lower debts.

In February 2024, the Official Gazette published the appointment of as managing director.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Apotheek Antverpia

What is the company number of Apotheek Antverpia?
The company number of Apotheek Antverpia is 0404.751.702. The VAT number is the same number with BE in front: BE 0404.751.702.
Where is Apotheek Antverpia based?
The registered office is at Blauwesteenstraat 95, 2550 Kontich.Company details
What does Apotheek Antverpia do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Apotheek Antverpia?
Apotheek Antverpia is a public limited company (NV).
When was Apotheek Antverpia founded?
Apotheek Antverpia was founded on 01-01-1968.
Is Apotheek Antverpia still active?
Yes, Apotheek Antverpia is an active enterprise in the KBO register.
How many employees does Apotheek Antverpia have?
Apotheek Antverpia had an average of 172.5 full-time equivalents in financial year 2024, according to the filed annual accounts.Financials
Which joint committee does Apotheek Antverpia fall under?
In its 2024 annual accounts, Apotheek Antverpia states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of Apotheek Antverpia?
The turnover of Apotheek Antverpia was €65.6m in financial year 2024, according to the filed annual accounts.
Is Apotheek Antverpia profitable?
In financial year 2024, Apotheek Antverpia made a profit of €449,079.
Where can I find the annual accounts of Apotheek Antverpia?
Apotheek Antverpia filed 48 annual accounts with the National Bank of Belgium, the latest for financial year 2024.

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.